Individualized Extension of Pegylated Interferon Plus Ribavirin Therapy for Recurrent Hepatitis C Genotype 1b After Living-Donor Liver Transplantation-Reference-Cited by-同舟云学术

Individualized Extension of Pegylated Interferon Plus Ribavirin Therapy for Recurrent Hepatitis C Genotype 1b After Living-Donor Liver Transplantation

Published:2010-09-27 Issue:6 Volume:90 Page:661-665
ISSN:0041-1337
Container-title:Transplantation
language:en
Short-container-title:

Author:

Ueda Yoshihide,Takada Yasutsugu,Marusawa Hiroyuki,Egawa Hiroto,Uemoto Shinji,Chiba Tsutomu

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Transplantation

Reference22 articles.

1. Contribution of donor age to the recent decrease in patient survival among HCV-infected liver transplant recipients.;Berenguer;Hepatology,2002

2. European collaborative study on factors influencing outcome after liver transplantation for hepatitis C. European Concerted Action on Viral Hepatitis (EUROHEP) Group.;Feray;Gastroenterology,1999

3. The association between hepatitis C infection and survival after orthotopic liver transplantation.;Forman;Gastroenterology,2002

4. The natural history and outcome of liver transplantation in hepatitis C virus-infected recipients.;Gane;Liver Transpl,2003

5. High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation: relationship with rejection episodes.;Prieto;Hepatology,1999

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Selection Criteria and Current Issues in Liver Transplantation for Hepatocellular Carcinoma;Liver Cancer;2016-03-17

2. Impact of elderly donors for liver transplantation: A single-center experience;Liver Transplantation;2015-04-15

3. Steroid minimization immunosuppression protocol using basiliximab in adult living donor liver transplantation for hepatitis C virus-related cirrhosis;Hepatology Research;2015-02-26

4. Impact of new treatment options for hepatitis C virus infection in liver transplantation;World Journal of Gastroenterology;2015

5. Sustained virological response to antiviral therapy improves survival rate in patients with recurrent hepatitis C virus infection after liver transplantation;Hepatology Research;2014-12-02